Stocks · Health care · Pharmaceutical Preparations

Bicara Therapeutics Inc.

BCAX Clue Score37
United States Fiscal year ends December CIK 0002023658 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
26 Feb 2026
Director
Buy indirect
300,000
$16.00
$4.80M
James E Flynn
17 Sep 2024
10% owner
Buy indirect
35,000
$18.00
$630.00K
James E Flynn
17 Sep 2024
10% owner
Buy indirect
35,000
$18.00
$630.00K
Ra Capital Management, L.p.
16 Sep 2024
Director
Buy indirect
152,480
$18.00
$2.74M
Ra Capital Management, L.p.
16 Sep 2024
Director
Buy indirect
1,680,520
$18.00
$30.25M

What was left out

Form 4 filings counted 84
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 73
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 23,299,906
History held since 16 Sep 2024